A carregar...

4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review

This systematic review summarizes the existing evidence on the effect of 4-aminopyridine (4-AP) as a symptomatic treatment of decreased walking capacity in patients with multiple sclerosis (MS) when administered as an immediate release compound and a slow release compound. It summarizes existing evi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jensen, Henrik Boye, Ravnborg, Mads, Dalgas, Ulrik, Stenager, Egon
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3932769/
https://ncbi.nlm.nih.gov/pubmed/24587826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285613512712
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!